402718-16-5

Upstream product

• 355004-66-9 N-(((5S)-3-(4-(2,2-dibromovinyl)-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide 
• 98-80-6 phenylboronic acid 
• 355004-64-7 2-(((5S)-3-(4-(2,2-dibromovinyl)-3-fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)-1H-isoindole-1,3(2H)-dione 
• 352524-61-9 4-((5S)-5-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)-2-oxo-1,3-oxazolidin-3-yl)-2-fluorobenzaldehyde 
• 57848-46-1 4-bromo-2-fluorobenzaldehyde 

Relevant academic research and scientific papers

The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class.

A novel series of antimicrobials of the oxazolidinone class is disclosed. These compounds are characterized relative to previously described analogues by a 'halostilbene-derived' pharmacophore and demonstrate enhanced antimicrobial activity against key Gram-positive pathogens when compared to Linezolid.

Oxazolidinone chemotherapeutic agents

Compounds of formula (I) or therapeutically acceptable salts or prodrugs thereof, are useful for treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy. Preparation of the compounds, compositions containing the compounds, an